Garwood Medical Devices recently announced that it and a University of Buffalo research team have won a $749,000 federal grant to evaluate a medical device to prevent, control, and eliminate bacterial biofilm infections associated with orthopedic implants. Garwood is licensing the technology behind the BioPrax device, a cathodic voltage-controlled electrical stimulation (CVCES) patented by the University […]
Garwood Medical
Garwood Medical raises $4M in Series C round
Garwood Medical Devices announced today that it raised $4 million in a Series C financing round to support preclinical testing for BioPrax. Buffalo, N.Y.-based Garwood Medical develops the BioPrax device for minimally invasive procedures for eliminating biofilm infections on prosthetic joints during early intervention procedures. The device received FDA breakthrough device designation in October 2019. […]
Garwood Medical Devices’ Series B round oversubscribes by $700,000
Garwood Medical Devices announced last week that it closed its Series B financing round at $3.7 million. The round was oversubscribed by $700,000. The Buffalo, N.Y.-based medical device developer closed the funding round on Nov. 30. The WNY ImpactInvestment fund contributed $500,000 to the Series B, while 17 investors from the company’s $3.6 million Series […]
Garwood Medical wins FDA breakthrough nod for biofilm disruption device
Garwood Medical Devices said today that it has won FDA breakthrough device designation for the BioPrax device for eliminating biofilm infections on prosthetic knee implants. BioPrax is a minimally invasive device designed to deliver a low-voltage electrical treatment to the surface of a knee implant and kill bacteria associated with biofilm infections. The device has […]
Could electrical stimulation reduce joint replacement infections?
The Buffalo, N.Y.–based startup Garwood Medical Devices is betting that electrical stimulation technology it has licensed from the University at Buffalo could make joint replacement infections less common. Garwood is presently raising $3 million in a series B round and is engaged in another round of animal testing of its Biofilm Disruption Device (BDD), according […]
Infection-detection tech dev Garwood Medical raises $2m in Series A
Garwood Medical raised $2 million in a Series A round of financing to support medical the development of devices which detect and report on possible infections, according to an SEC filing. The company was founded in 2014 and has the exclusive license for 3 patents from the University at Buffalo, and has developed 3 additional […]